The 2025-2030 World Outlook for Point of Care (PoC) Lipid Tests - Image 1

Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Point of Care (PoC) Lipid Tests

Subjects

Out of Stock

Price data last checked 138 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 138 days. Could come back at any time — we're watching for you.

Out of stock 138 days · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

This study covers the world outlook for point of care (PoC) lipid tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of point of care (PoC) lipid tests as including all commonly understood products falling within this broad category, such as lipid tests used for hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hyperlipoproteinemia, and tangier disease and lipid test instruments and consumables, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abaxis, Abbott, AccuBioTech Company, BD, Bio-Rad Laboratories, Chembio Diagnostic Systems, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Johnson & Johnson, Nova Biomedical, PTS Diagnostics, Quidel Corporation, Samsung Medison Company, Sekisui Diagnostics, Siemens, The Menarini Group, and Trinity Biotech. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZLXCLHN
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 06 May 2024

The 2025-2030 World Outlook for Point of Care (PoC) Lipid Tests

Gone for 138 days. Could come back at any time — we're watching for you.

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Similar Products You Might Like

The 2025-2030 World Outlook for Point of Care Diagnostics

The 2027-2032 World Outlook for Biotechnology Reagents

The 2025-2030 World Outlook for Point of Care Analyzers

The 2027-2032 World Outlook for Biotechnology Immunoassay Instrumentation Systems

The 2023 Report on Point of Care Diagnostics: World Market Segmentation by City

Lipoproteins in Diabetes Mellitus (Contemporary Diabetes)

The 2026-2031 World Outlook for Lateral Flow Assay Meningitis Diagnostic Testing

The 2023 Report on DNA Testing: World Market Segmentation by City

HDL Metabolism and Diseases: Includes Digital Download: 1377 (Advances in Experimental Medicine and Biology, 1377)

Wallach's Interpretation of Diagnostic Tests

Lipid Metabolism and Health

The 2027-2032 World Outlook for At-Home Drug of Abuse Testing

The 2027-2032 World Outlook for Biotechnology Molecular Diagnostics

Volatile Organic Compound Analysis in Biomedical Diagnosis Applications

High-Density Lipoproteins as Biomarkers and Therapeutic Tools: Volume 1. Impacts of Lifestyle, Diseases, and Environmental Stressors on HDL

Lipoproteins and Cardiovascular Disease: Methods and Protocols: 1027 (Methods in Molecular Biology, 1027)

Lipid Metabolism and Health

Metallocorroles for Attenuation of Atherosclerosis: 120 (Springer Theses)

Therapeutic Lipidology (Contemporary Cardiology)

Lipoproteins and Cardiovascular Disease: Methods and Protocols: 1027 (Methods in Molecular Biology, 1027)

The 2025-2030 World Outlook for Portable Medical Electronic Products

Clinical Chemistry: Fundamentals and Laboratory Techniques

The 2025-2030 World Outlook for Tissue Banking Equipment and Consumables

Molecular Diagnostics: 133 (Advances in Biochemical Engineering/Biotechnology, 133)